|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 160.50 ARS | 0.00% |
|
0.00% | -33.26% |
| Market Cap | 683.56Cr 47.6L 41.07L 37.76L 35.54L 66.78L 45Cr 67.34L 4.47Cr 1.74Cr 22Cr 1.79Cr 1.75Cr 76Cr | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 757.33Cr 52.74L 45.5L 41.83L 39.37L 73.98L 50Cr 74.6L 4.96Cr 1.93Cr 24Cr 1.98Cr 1.94Cr 85Cr | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| Current month | -3.60% | ||
| 3 months | -13.94% | ||
| 6 months | -25.69% | ||
| Current year | -33.26% |
| 1 week | 160 | 169.5 | |
| 1 month | 155 | 176.5 | |
| Current year | 128.5 | 260 | |
| 1 year | 116 | 357 | |
| 3 years | 21 | 450 | |
| 5 years | 9.1 | 450 | |
| 10 years | 4 | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 30/07/2010 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -57.76% | +669.78% | 47.68L | ||
| 0.00% | -2.13% | -50.79% | -52.90% | 3.33TCr | ||
| +0.54% | +6.34% | +78.69% | +137.73% | 1.21TCr | ||
| +0.41% | -3.82% | +1.97% | +23.83% | 445.57Cr | ||
| -1.48% | -3.07% | +4.73% | +16.29% | 327.61Cr | ||
| -3.88% | -0.58% | +56.79% | +23.70% | 200.12Cr | ||
| -3.16% | +5.88% | -24.29% | +2.27% | 178.35Cr | ||
| +0.08% | +2.05% | +30.14% | +127.77% | 129.28Cr | ||
| -2.30% | -0.33% | -24.03% | -12.27% | 105.19Cr | ||
| -3.31% | -2.13% | -8.14% | -47.25% | 100.45Cr | ||
| Average | -1.29% | +0.03% | +0.73% | +88.90% | 602.29Cr | |
| Weighted average by Cap. | -0.23% | -2.12% | -10.58% | +3.76% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 827.49Cr 57.62L 49.71L 45.71L 43.02L 80.84L 54Cr 81.52L 5.42Cr 2.11Cr 27Cr 2.16Cr 2.12Cr 92Cr | 640.36Cr 44.59L 38.47L 35.37L 33.29L 62.56L 42Cr 63.08L 4.19Cr 1.63Cr 21Cr 1.67Cr 1.64Cr 71Cr |
| Net income | -141.73Cr -10L -9L -8L -7L -13.85L -9.31Cr -13.96L -92.77L -36.12L -4.57Cr -37.04L -36.25L -16Cr | -459.77Cr -32.02L -27.62L -25.39L -23.9L -44.92L -30Cr -45.29L -3.01Cr -1.17Cr -15Cr -1.2Cr -1.18Cr -51Cr |
| Net Debt | 86Cr 6L 5L 5L 4L 8L 5.67Cr 9L 56.5L 22L 2.78Cr 22.56L 22.08L 9.63Cr | 74Cr 5L 4L 4L 4L 7L 4.85Cr 7L 48.29L 18.8L 2.38Cr 19.28L 18.87L 8.23Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 160.50 $ | 0.00% | 16,450 |
| 12/26/12 | 160.50 $ | -0.62% | 4,200 |
| 11/26/11 | 161.50 $ | 0.00% | 9,352 |
| 10/26/10 | 161.50 $ | +0.62% | 11,082 |
| 09/26/09 | 160.50 $ | +0.31% | 12,579 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
















